Repatha and Abdominal pain lower - a phase IV clinical study of FDA data

Summary:

Abdominal pain lower is reported as a side effect among people who take Repatha (evolocumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zetia, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Abdominal pain lower when taking Repatha. It is created by eHealthMe based on reports of 155,838 people who have side effects when taking Repatha from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,256 Repatha users. Check the latest studies of Repatha.

What is Abdominal pain lower?

Abdominal pain lower is found to be associated with 1,186 drugs and 2,177 conditions by eHealthMe. Check the latest studies of Abdominal pain lower.

On Jul, 12, 2026

155,838 people reported to have side effects when taking Repatha.
Among them, 53 people (0.03%) have Abdominal pain lower.

Could Repatha cause Abdominal pain lower?

Among these 53 people:

How long have people been on Repatha when they have Abdominal pain lower? *

What is the gender of people who have Abdominal pain lower when taking Repatha? *

female: 50.98 %
male: 49.02 %

What is the age of people who have Abdominal pain lower when taking Repatha? *

What are other drugs people take besides Repatha? *

What are other side effects people have besides Abdominal pain lower? *

Back Pain: 8 people, 15.09%
Pain In Extremity: 8 people, 15.09%
Diarrhea: 6 people, 11.32%
Joint Pain: 6 people, 11.32%
Muscle Aches (muscle pain): 6 people, 11.32%
Pain: 6 people, 11.32%
Groin Pain: 5 people, 9.43%
Injection Site Pain: 5 people, 9.43%
Abdominal Discomfort: 4 people, 7.55%
Gait Disturbance: 4 people, 7.55%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 9.43%
Low Density Lipoprotein Increased (cholesterol increased in blood): 2 people, 3.77%
Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 3.77%
Type 2 Diabetes: 1 person, 1.89%
Stable Angina (a constant chest pain): 1 person, 1.89%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.89%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 1.89%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 1.89%
Pain: 1 person, 1.89%
Lipids Increased (excess lipid in body): 1 person, 1.89%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and have Abdominal pain lower?

- Check whether Abdominal pain lower is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Repatha:

Repatha (156,256 reports)

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain lower:

Abdominal pain lower (1,186 drugs)

Browse all the conditions that are associated with Abdominal pain lower:

Abdominal pain lower (2,177 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on evolocumab (the active ingredients of Repatha) and Repatha (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.